Investigating nitroglycerin and misoprostol on cervical ripening
Phase 3
Recruiting
- Conditions
- Hysteroscopy candidate patients.
- Registration Number
- IRCT20191123045476N4
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 84
Inclusion Criteria
age between 18-50 years (reproductive age)
history of at least one Normal Vaginal Delivery
being a candidate for hysteroscopy
Exclusion Criteria
history of drug allergy
cardiovascular diseases
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cervical dilatation. Timepoint: Immediately after taking the drug during surgery. Method of measurement: In the operating room, the opening of the cervix is measured in millimeters using sized dilators.
- Secondary Outcome Measures
Name Time Method